INO

#4124
Inovio Pharmaceuticals, Inc.
1.12 USD
+2.75%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.11
1.13
년간 변동
1.03
2.98
일일 변동
+2.75%
월간 변동
-32.93%
6달 변화
-54.84%
년간 변동율
-36.72%
이전 종가
1.09
Open
1.12
Bid
Ask
Low
1.11
High
1.13
양
90
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 77.38 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.96
Price to sales ratio
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

뉴스